A Phase 1b/2 Study of Gemcitabine-Cisplatin, With or Without LY2275796 Sodium, in Patients with Advanced Stage IIIB or IV Non-Small Cell Lung Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 27 Nov 2012
At a glance
- Drugs ISIS EIF4ERx (Primary) ; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Jul 2011 New trial record